FOR2240-Logo2FOR2240-Logo2FOR2240-Logo2FOR2240-Logo2
  • Home
  • About
  • Projects
    • P1 Lymph-Transplant
    • P2 Modulators of LA
    • N1 Ocular GvHD
    • N2 ABCB5 & Pterygium
    • P4 Ocular Melanoma
    • P5 Myeloid Cells
    • P6 Microglia in AMD
    • P8 Uveitis
    • C1 Eye Imaging
    • C2 Management
  • Team
    • Executive Board
    • Research Groups
    • Central Projects
    • Associated projects
    • Alumni
  • Publications
  • Links
  • News
✕
Published by Robert on March 8, 2022
Categories
for2240 | Martina Maaß
  • DateMarch 8, 2022
  • Executive Board
  • Research Groups
  • Central Projects
  • Associated projects
  • Alumni

Curriculum Vitae

Martina Maaß

for2240 | Martina Maaß

Department of Ophthalmology
Division of Dry-Eye and ocular GVHD
Ocular Surface Group
University of Cologne
Kerpener Strasse 62
50937 Cologne, GERMANY
Email: martina.maass@uk-koeln.de

Scientific career

2003 Diploma Biology, Martin-Luther-University Halle-Wittenberg

2009 – 2018 Scientist and PhD student, Department of Internal Medicine III, University Hospital of Cologne

since 2011 Scientist, Department of Ophthalmology, Ocular Surface Group, University Hospital of Cologne

2020 PhD, Department of Internal Medicine III, University Hospital of Cologne

since 2020 Affiliated Scientist of Project N1 “Lymph- and hemangiogenesis in ocular Graft-versus-Host Disease” of the DFG Research Unit FOR 2240 “Angiogenesis, Lymphangiogenesis and Cellular Immunity in Inflammatory Diseases of the Eye” at the Department of Ophthalmology, University of Cologne

since 2022 Senior Scientist of the Dry-Eye and ocular GVHD group

Selected publications

Tran BN, Maass M, Musial G, Stern ME, Gehlsen U, Steven P. Topical application of cannabinoid-ligands ameliorates experimental dry-eye disease. Ocul Surf. 2022; 23: 131-139

Guthoff H, Hof A, Klinke A, Maaß M, Konradi J, Mehrkens D, Geißen S, Nettersheim FS, Braumann S, Michaelsson E, Nies RJ, Lee S, Redzinski MC, Peters VBM, Nemade HN, von Stein P, Winkels H, Rudolph V, Baldus S, Adam M, Mollenhauer M. Protective Effects of Therapeutic Neutrophil Depletion and Myeloperoxidase Inhibition on Left Ventricular Function and Remodeling in Myocardial Infarction. Antioxidants (Basel). 2022; 12 (1): 33

Gehlsen U, Stary D, Maass M, Riesner K, Musial G, Stern ME, Penack O, Steven P. Ocular Graft-versus-Host Disease in a Chemotherapy-Based Minor-Mismatch Mouse Model Features Corneal (Lymph-) Angiogenesis. Int J Mol Sci. 2021; 22 (12): 6191

Mollenhauer M, Bokredenghel S, Geißen S, Klinke A, Morstadt T, Torun M, Strauch S, Schumacher W, Maass M, Konradi J, Peters VBM, Berghausen E, Vantler M, Rosenkranz S, Mehrkens D, Braumann S, Nettersheim F, Hof A, Simsekyilmaz S, Winkels H, Rudolph V, Baldus S, Adam M, Freyhaus HT. Stamp2 Protects From Maladaptive Structural Remodeling and Systolic Dysfunction in Post-Ischemic Hearts by Attenuating Neutrophil Activation. Front Immunol. 2021; 12: 701721

Peinkofer G, Maass M, Pfannkuche K, Sachinidis A, Baldus S, Hescheler J, Saric T, Halbach M. Persistence of intramyocardially transplanted murine induced pluripotent stem cell-derived cardiomyocytes from different developmental stages. Stem Cell Res Ther. 2021; 12 (1): 46

Sahito RGA, Sheng X, Maass M, Mikhael N, Hamad S, Heras-Bautista CO, Derichsweiler D, Spitkovsky D, Suhr F, Khalil M, Brockmeier K, Halbach M, Saric T, Hescheler J, Krausgrill B, Pfannkuche K. In Vitro Grown Micro-Tissues for Cardiac Cell Replacement Therapy in Vivo. Cell Physiol Biochem. 2019; 52(6): 1309-1324

Mollenhauer M, Friedrichs K, Lange M, Gesenberg J, Remane L, Kerkenpaß C, Krause J, Schneider J, Ravekes T, Maass M, Halbach M, Peinkofer G, Saric T, Mehrkens D, Adam M, Deuschl FG, Lau D, Geertz B, Manchanda K, Eschenhagen T, Kubala L, Rudolph TK, Wu Y, Tang WHW, Hazen SL, Baldus S, Klinke A, Rudolph V. Myeloperoxidase Mediates Postischemic Arrhythmogenic Ventricular Remodeling. Circ Res. 2017; 121(1): 56-70

Maass M, Krausgrill B, Eschrig S, Kaluschke T, Urban K, Peinkofer G, Plenge TG, Oeckenpöhler S, Raths M, Ladage D, Halbach M, Hescheler J, Müller-Ehmsen J. Intramyocardially Transplanted Neonatal Cardiomyocytes (NCMs) Show Structural and Electrophysiological Maturation and Integration and Dose-Dependently Stabilize Function of Infarcted Rat Hearts. Cell Transplant. 2017, 26(1): 157-170

Keller K, Maass M, Dizayee S, Leiss V, Annala S, Köth J, Seemann WK, Müller-Ehmsen J,Mohr K, Nürnberg B, Engelhardt S, Herzig S, Birnbaumer L,Matthes J. Lack of Gαi2 leads to dilative cardiomyopathy and increased mortality in β1-adrenoceptor overexpressing mice. Cardiovasc Res. 2015; 108(3): 348-56

Rinschen MM, Pahmeyer C, Pisitkun T, Schnell N, Wu X, Maaß M, Bartram MP, Lamkemeyer T, Schermer B, Benzing T, Brinkkoetter PT. Comparative phosphoproteomic analysis of mammalian glomeruli reveals conserved podocin C-terminal phosphorylation as a determinant of slit diaphragm complex architecture. Proteomics. 2015; 15(7): 1326-31.

Baumgartner S*, Halbach M*, Sahito RG, Krausgrill B, Maass M, Peinkofer G, Ladage D, Hescheler J, Müller-Ehmsen J. Electrophysiological and morphological maturation of murine fetal cardiomyocytes during electrical stimulation in vitro. Journal of Cardiovascular Pharmacology and Therapeutics. 2015; 20(1): 104-12.

Halbach M*, Baumgartner S*, Sahito RG, Krausgrill B, Maass M, Peinkofer G, Ladage D, Hescheler J, Müller-Ehmsen J. Cell persistence and electrical integration of transplanted fetal cardiomyocytes from different developmental stages. Int J Cardiol. 2014; 171(3): e122-4.

Halbach M*, Peinkofer G*, Baumgartner S, Maass M, Wiedey M, Neef K, Krausgrill B, Ladage D, Fatima A, Saric T, Hescheler J, Müller-Ehmsen J. Electrophysiological integration and action potential properties of transplanted cardiomyocytes derived from induced pluripotent stem cells. Cardiovasc Res. 2013; 100(3): 432-40.

More information

  • Publication highlights
  • Jobs
  • Contact
  • Impressum
  • Datenschutz

Newest publications

Supplemental Anti Vegf A-Therapy Prevents Rebound…(2020)


Bevacizumab Induces Upregulation of Keratin 3 and VEGFA in Human…(2020)


Immune reactions after modern lamellar (DALK, DSAEK, DMEK) versus conventional…(2020)


Contact

Claudia Bock
Management Office
DFG Research Unit FOR2240
Department of Ophthalmology
University of Cologne
Kerpener Str. 62
50937 Cologne, Germany

www.for2240.de

Tel. +49 (0)221 478 32845
Fax. +49 (0)221 478 5094
claudia.bock@uk-koeln.de

Partnerlogos

© 2021 FOR2240 | Online Marketing von Resulted Lübeck
      Um unsere Website für Sie optimal zu gestalten und fortlaufend verbessern zu können, verwenden wir Cookies. Durch die weitere Nutzung der Webseite stimmen Sie der Verwendung von Cookies zu. Weitere Informationen zu Cookies und insb. der Möglichkeiten, der Verwendung von Cookies zu widersprechen, erhalten Sie in unserer Datenschutzerklärung.SchließenDatenschutzerklärung